SELLAS Life Sciences Group Inc (SLS)
1.455
-0.06
(-4.28%)
USD |
NASDAQ |
Apr 26, 16:00
1.455
0.00 (0.00%)
After-Hours: 19:16
SELLAS Life Sciences Group Cash from Operations (TTM): -31.41M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -31.41M |
| September 30, 2023 | -31.74M |
| June 30, 2023 | -30.59M |
| March 31, 2023 | -28.79M |
| December 31, 2022 | -23.81M |
| September 30, 2022 | -23.63M |
| June 30, 2022 | -23.76M |
| March 31, 2022 | -22.90M |
| December 31, 2021 | -26.02M |
| September 30, 2021 | -17.62M |
| June 30, 2021 | -15.37M |
| March 31, 2021 | -13.86M |
| December 31, 2020 | -10.42M |
| September 30, 2020 | -18.02M |
| June 30, 2020 | -18.21M |
| March 31, 2020 | -19.48M |
| December 31, 2019 | -17.64M |
| September 30, 2019 | -18.02M |
| June 30, 2019 | -28.37M |
| March 31, 2019 | -30.01M |
| December 31, 2018 | -30.42M |
| September 30, 2018 | -10.62M |
| June 30, 2018 | -15.84M |
| March 31, 2018 | -12.59M |
| December 31, 2017 | -10.99M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.173M |
| June 30, 2017 | 6.005M |
| March 31, 2017 | -2.437M |
| December 31, 2016 | -11.85M |
| September 30, 2016 | -52.20M |
| June 30, 2016 | -49.45M |
| March 31, 2016 | -49.82M |
| December 31, 2015 | -48.16M |
| September 30, 2015 | -43.61M |
| June 30, 2015 | -45.26M |
| March 31, 2015 | -46.38M |
| December 31, 2014 | -42.87M |
| September 30, 2014 | -40.63M |
| June 30, 2014 | -37.50M |
| March 31, 2014 | -31.65M |
| December 31, 2013 | -28.93M |
| September 30, 2013 | -25.62M |
| June 30, 2013 | -21.80M |
| March 31, 2013 | -21.42M |
| December 31, 2012 | -20.97M |
| September 30, 2012 | -19.96M |
| June 30, 2012 | -19.21M |
| March 31, 2012 | -16.53M |
| December 31, 2011 | -14.67M |
| September 30, 2011 | -12.37M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-31.74M
Minimum
Sep 2023
-10.42M
Maximum
Dec 2020
-22.09M
Average
-22.90M
Median
Mar 2022
Cash from Operations (TTM) Benchmarks
| Geron Corp | -167.74M |
| Immuneering Corp | -48.97M |
| Protagonist Therapeutics Inc | -70.24M |
| Akebia Therapeutics Inc | -23.38M |
| Moderna Inc | -3.118B |